IDEXX Laboratories
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $975,543 | $1,003,578 | $964,095 | $901,601 |
Gross Profit | 594,317 | 620,880 | 593,070 | 526,167 |
EBITDA | 207,595 | 297,715 | 333,294 | 245,302 |
EBIT | 269,692 | 265,522 | 303,390 | 215,565 |
Net Income | 232,841 | 203,298 | 235,579 | 194,521 |
Net Change In Cash | 975,543 | 1,003,578 | 964,095 | 901,601 |
Free Cash Flow | 191,990 | 215,007 | 168,312 | 217,295 |
Cash | 308,636 | 401,590 | 397,433 | 453,932 |
Basic Shares | 83,393 | 83,393 | 83,957 | 83,933 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $3,660,953 | $3,367,324 | $3,215,360 | $2,706,655 |
Gross Profit | 2,189,970 | 2,004,338 | 1,889,432 | 1,571,040 |
EBITDA | 1,097,128 | 1,010,665 | 1,036,624 | 790,522 |
EBIT | 1,097,128 | 898,765 | 932,028 | 694,524 |
Net Income | 845,042 | 679,089 | 744,845 | 581,776 |
Net Change In Cash | 3,660,953 | 3,367,324 | 3,215,360 | 2,706,655 |
Cost of Revenue | -23,302 | -234,835 | 290,271 | |
Free Cash Flow | 772,879 | 394,146 | 635,997 | 540,437 |
Cash | 453,932 | 112,546 | 144,454 | 383,928 |
Basic Shares | 83,978 | 84,600 | 86,572 | 86,722 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $2.80 |
2024-06-30 | $3.02 |
2024-03-31 | $2.81 |
2023-12-31 | $2.32 |
